Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis

Life Sciences

Volumn 84, Issue 1-2, 2009, Pages 28-32

  Hong, Samin ^a   Kim, Chan Yun ^a   Lee, Jong Eun ^a   Seong, Gong Je ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Agmatine; Glaucoma; Retinal ganglion cell; Tumor necrosis factor

Indexed keywords

AGMATINE; HOE 33342; LACTATE DEHYDROGENASE; LIPOCORTIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL LOSS; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ASSAY; ENZYME RELEASE; EXPOSURE VARIABLE; IN VITRO STUDY; NONHUMAN; RAT; RETINA GANGLION CELL;

AGMATINE; ANIMALS; APOPTOSIS; CELLS, CULTURED; L-LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENTS; RATS; RETINAL GANGLION CELLS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 57649227691     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.10.006     Document Type: Article

References (44)

1. Anthony R.S., McKelvie N.D., Cunningham A.J., Craig J.I., Rogers S.Y., and Parker A.C. Flow cytometry using annexin V can detect early apoptosis in peripheral blood stem cell harvests from patients with leukaemia and lymphoma. Bone Marrow Transplantation 21 5 (1998) 441-446
2. Chauhan B.C., and Drance S.M. The relationship between intraocular pressure and visual field progression in glaucoma. Graefe's Archive for Clinical and Experimental Ophthalmology 230 6 (1992) 521-526
3. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. American Journal of Ophthalmology 126 4 (1998) 498-505
4. Dielemans I., Vingerling J.R., Wolfs R.C., Hofman A., Grobbee D.E., and de Jong P.T. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 101 11 (1994) 1851-1855
5. Dudkowska M., Lai J., Gardini G., Stachurska A., Grzelakowska-Sztabert B., Colombatto S., and Manteuffel-Cymborowska M. Agmatine modulates the in vivo biosynthesis and interconversion of polyamines and cell proliferation. Biochimica et Biophysica Acta 1619 2 (2003) 159-166
6. Feng Y., and LeBlanc M.H. Effect of agmatine on the time course of brain inflammatory cytokines after injury in rat pups. Annals of the New York Academy of Sciences 1009 (2003) 152-156
7. Galea E., Regunathan S., Elio.poulos V., Feinstein D.L., and Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochemical Journal 316 Pt 1 (1996) 247-249
8. Gilad G.M., and Gilad V.H. Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neuroscience Letters 296 2-3 (2000) 97-100
9. Gilad G.M., Salame K., Rabey J.M., and Gilad V.H. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sciences 58 2 (1996) PL41-PL46
10. Grillo M.A., and Colombatto S. Metabolism and function in animal tissues of agmatine, a biogenic amine formed from arginine. Amino Acids 26 1 (2004) 3-8
11. Heijl A., Leske M.C., Bengtsson B., Hyman L., Bengtsson B., Hussein M., and Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology 120 10 (2002) 1268-1279
12. Hong S., Lee J.E., Kim C.Y., and Seong G.J. Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neuroscience 8 (2007) 81
13. Kalra S.P., Pearson E., Sahu A., and Kalra P.S. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neuroscience Letters 194 3 (1995) 165-168
14. Kass M.A., Kolker A.E., and Becker B. Prognostic factors in glaucomatous visual field loss. Archives of Ophthalmology 94 8 (1976) 1274-1276
15. Kaushik S., Pandav S.S., and Ram J. Neuroprotection in glaucoma. Journal of Postgraduate Medicine 49 1 (2003) 90-95
16. Kim J.H., Yenari M.A., Giffard R.G., Cho S.W., Park K.A., and Lee J.E. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Experimental Neurology 189 1 (2004) 122-130
17. Kitaoka Y., Kitaoka Y., Kwong J.M., Ross-Cisneros F.N., Wang J., Tsai R.K., Sadun A.A., and Lam T.T. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Investigative Ophthalmology & Visual Science 47 4 (2006) 1448-1457
18. Koh J.Y., and Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. Journal of Neuroscience Methods 20 1 (1987) 83-90
19. Kolesnikov Y., Jain S., and Pasternak G.W. Modulation of opioid analgesia by agmatine. European Journal of Pharmacology 296 1 (1996) 17-22
20. Kotil K., Kuscuoglu U., Kirali M., Uzun H., Akçetin M., and Bilge T. Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial. Journalof Neurosurgery. Spine 4 5 (2006) 392-399
21. Krishnamoorthy R.R., Agarwal P., Prasanna G., Vopat K., Lambert W., Sheedlo H.J., Pang I.H., Shade D., Wordinger R.J., Yorio T., Clark A.F., and Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Brain Research. Molecular Brain Research 86 1-2 (2001) 1-12
22. Kuehn M.H., Fingert J.H., and Kwon Y.H. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmology clinics of North America 18 3 (2005) 383-395
23. Lee Y.S., Song Y.S., Giffard R.G., and Chan P.H. Biphasic role of nuclear factor-kappa B on cell survival and COX-2 expression in SOD1 Tg astrocytes after oxygen glucose deprivation. Journal of Cerebral Blood Flow and Metabolism 26 8 (2006) 1076-1088
24. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 5149 (1994) 966-969
25. Moreau T., Coles A., Wing M., Isaacs J., Hale G., Waldmann H., and Compston A. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119 Pt1 (1996) 225-237
26. Nakazawa T., Matsubara A., Noda K., Hisatomi T., She H., Skondra D., Miyahara S., Sobrin L., Thomas K.L., Chen D.F., Grosskreutz C.L., Hafezi-Moghadam A., and Miller J.W. Characterization of cytokine responses to retinal detachment in rats. Molecular Vision 12 (2006) 867-878
27. Olmos G., DeGregorio-Rocasolano N., Paz Regalado M., Gasull T., Assumpció Boronat M., Trullas R., Villarroel A., Lerma J., and García-Sevilla J.A. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. British Journal of Pharmacology 127 6 (1999) 1317-1326
28. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P., and Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Survey of Ophthalmology 43 Suppl 1 (1999) S102-S128
29. Ramadan R.T., Ramirez R., Novosad B.D., and Callegan M.C. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Current Eye Research 31 11 (2006) 955-965
30. Sawada M., Imamura K., and Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. Journal of Neural Transmission. Supplementum 70 (2006) 373-381
31. Sener A., Lebrun P., Blachier F., and Malaisse W.J. Stimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine. Biochemical Pharmacology 38 2 (1989) 327-330
32. Su R.B., Li J., and Qin B.Y. A biphasic opioid function modulator: agmatine. Acta Pharmacologica Sinica 24 7 (2003) 631-636
33. Tarkowski E., Andreasen N., Tarkowski A., and Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 74 9 (2003) 1200-1205
34. Tezel G., and Wax M.B. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. Journal of Neuroscience 20 23 (2000) 8693-8700
35. Tezel G., Li L.Y., Patil R.V., and Wax M.B. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Investigative Ophthalmology & Visual Science 42 8 (2001) 1787-1794
36. Wang J., Ma J.H., and Giffard R.G. Overexpression of copper/zinc superoxide dismutase decreases ischemia-like astrocyte injury. Free Radical Biology & Medicine 38 8 (2005) 1112-1118
37. Wang W.P., Iyo A.H., Miguel-Hidalgo J., Regunathan S., and Zhu M.Y. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Research 1084 1 (2006) 210-216
38. Werner E.B., and Drance S.M. Progression of glaucomatous field defects despite successful filtration. Canadian Journal of Ophthalmology 12 4 (1977) 275-280
39. Wroblewski F., and Ladue J.S. Lactic dehydrogenase activity in blood. Proceedings of the Society for Experimental Biology and Medicine 90 1 (1955) 210-213
40. Yan X., Tezel G., Wax M.B., and Edward D.P. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Archives of Ophthalmology 118 5 (2000) 666-673
41. Yoshida S., Yoshida A., and Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefe's Archive for Clinical and Experimental Ophthalmology 242 5 (2004) 409-413
42. Yu C.G., Marcillo A.E., Fairbanks C.A., Wilcox G.L., and Yezierski R.P. Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport 11 14 (2000) 3203-3207
43. Yuan L., and Neufeld A.H. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32 1 (2000) 42-50
44. Zhu M.Y., Piletz J.E., Halaris A., and Regunathan S. Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cellular and Molecular Neurobiology 23 4-5 (2003) 865-872